跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

AI Antibody Design vs Human Design: A Conceptual Overview

1Why Antibody Design Matters2How Humans Design Antibodies3How AI Learns to Design Antibodies4Comparing AI and Human Design5Evidence, Limits, and Open Questions
Comparing AI and Human Design

Speed, Scale, and Novelty: Where the Two Approaches Diverge

1 / 3
Read the two columns as three separate questions, not one score. On speed and scale, the gap is structural: a human round is limited by physical steps, while computation can propose and rank thousands of sequences in the time one assay takes. On novelty, be careful — a generative model samples from patterns it learned, so its output is a new combination of known antibody features rather than something outside that space, and the further a candidate sits from the training data, the less its predicted score can be trusted. On reliability, the columns are not just different in degree: the human candidate already carries experimental evidence, while the AI candidate carries only a prediction.
0:00 / 0:00

The clearest differences between AI and human antibody design appear in three dimensions at once: how fast candidates can be produced, how many can be considered, and how far they stray from what is already known.

Speed and scale are linked. A human design cycle is limited by physical operations — immunizing an animal, growing cells, panning a library, expressing and assaying a variant. Each round of affinity maturation costs weeks and yields a small number of measured variants. An AI pipeline replaces the physical round with computation: a generative model can sample thousands of sequences and a scoring model can rank them in a fraction of that time. The asymmetry is not that AI is slightly faster; it is that AI searches a space that is too large to search physically.

Novelty is a separate axis and is easy to overstate. A generative model samples from a distribution learned from known antibody sequences, so its output is novel in the sense of being a new combination of learned patterns, not in the sense of being unrelated to anything in the training data. Novelty that falls far outside the learned distribution is exactly where the model's predictions become least trustworthy.

Reliability differs in kind. A human-derived candidate has already passed a real binding assay — the evidence and the candidate arrive together. An AI candidate arrives with a predicted score and no experimental evidence, so its reliability is inherited from how closely the new case resembles the model's training conditions.

上一页1 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion